Las Vegas, NV -- (SBWIRE) -- 10/07/2013 -- Value Stock Pick is a leading Investment Newsletter. Our Research Team conducts research on different stocks, doing their due diligence to provide a detailed report, including both technical and fundamental analysis, on NYSE, NASDAQ, AMEX, OTCBB and Pink Sheet Stocks. Let’s have a brief look at: Golden Star Resources Ltd. (USA) (NYSEMKT:GSS), Fab Universal Corp (NYSEMKT:FU), Catalyst Pharmaceutical Partners, Inc. (NASDAQ:CPRX), Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN).
Golden Star Resources Ltd. (USA) (NYSEMKT:GSS) managed to keep its fall at -5.49% on traded volume of 2.54 million shares. The stock settled at $0.430 after floating in a range of $0.43 to $0.47. After recent close, it has reached market capitalization of $111.42 million. Its 52-week range has been $0.39 to $2.11. Golden Star Resources Ltd. engages in the acquisition, exploration, development, and operation of gold properties.
Will GSS Get Buyers Even After The Recent Rally? Find Out Here
Fab Universal Corp (NYSEMKT:FU) traded down on a volume of 2.56 million, higher than its standard daily volume. Shares have dropped -9.06% to $5.02. Over the last twelve months the stock has added 5.91% and faced a worst price of $5.01. FAB Universal Corp. engages in the distribution of digital entertainment products and services worldwide. The company operates in three segments: Wholesale, Retail, and Kiosk/Licensing.
Will FU Get Buyers Even After The Recent Rally? Find Out Here
Catalyst Pharmaceutical Partners, Inc. (NASDAQ:CPRX) settled -3.24% lower at $3.28 on traded volume of 2.46 million shares during the last trading day, while its average trading volume remained 3.08 million shares. The stock has its 12-month low at $0.37 and 52-week high price was $3.65. It traded in a range of $3.21 to $3.52 during the last trading day. Catalyst Pharmaceutical Partners, Inc. operates as development-stage specialty pharmaceutical company.
Will CPRX Get Buyers Even After The Recent Rally? Find Out Here
Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) saw its price fall on traded volume as 2.51 million shares changed hands when compared with its average daily volume of 3.29 million shares. The stock was down -2.16% to $2.72. It has fallen over the last 12 months, dropping -75.5% and marked new low $2.62. Achillion Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes anti-infective drug therapies in the United States and internationally.
Will ACHN Get Buyers Even After The Recent Rally? Find Out Here
PLEASE NOTE WELL: The employees of ValueStockPick.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site, Press releases or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Please Read Our Full Disclaimer at http://www.valuestockpick.com/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)